More than 180,000 people die of burns every year, most of them in low- and middle-income countries, says the World Health Organization (WHO). In India alone, over a million people suffer from some degree of burns every year, as per the WHO. This factor will drive the global negative-pressure wound therapy (NPWT) devices market from $2,248.1 million in 2020 to $4,698.4 million in 2030, at a 7.7% CAGR between 2020 and 2030.

This is because NPWT is an advanced form of wound care that not only removes the exudate and infectious agents from the injured site, but also allows it to heal more rapidly than conventional therapies. In this regard, the booming geriatric population is also helping in the growth of the NPWT devices market, since older people’s wounds develop quickly and heal slowly, thereby creating a requirement for advanced techniques.

The COVID-19 pandemic hurt the NPWT devices market growth prospects due to the shutdown of manufacturing plants, which resulted in a lower incidence of burns. Moreover, since the entire focus of the healthcare, pharmaceutical, and medical device industries was on COVID-19 fight, the production of NPWT devices and their usage decreased.

The conventional category under the product segment is set to generate the highest NPWT devices market revenue in the coming years. These devices are widely accepted and used in emerging economies, such as China and India, the two most-populated nations on earth.

In the past, the NPWT devices market was dominated by the chronic bifurcation, under segmentation by wound type. With the increasing prevalence of chronic venous insufficiency, diabetes mellitus, and peripheral arterial occlusive disease, more people are suffering from chronic wounds each year. Since these wounds are more complex and take longer to heal, conventional wound care solutions often prove ineffective, thereby driving the usage of NPWT.

Hospitals are the largest end users in the negative-pressure wound therapy devices market presently because these places witness a high patient footfall each day. Since hospitals have many departments, trained doctors, and advanced facilities, they are trusted the most by patients. Moreover, governments are taking initiatives to make quality care accessible to everyone, such as the construction of public hospitals.

The fastest growth in the negative-pressure wound therapy devices market in the years to come will be witnessed in Asia-Pacific (APAC). The region has a high incidence of burns and diabetes, both of which often lead to chronic wounds. Additionally, the increasing geriatric population, which is highly vulnerable to wounds and wound-causing diseases, is propelling the regional market.